<DOC>
	<DOCNO>NCT00552188</DOCNO>
	<brief_summary>The purpose study determine effect VIA-2291 compare placebo vascular inflammation follow 24 week dose .</brief_summary>
	<brief_title>Phase 2 Study Vascular Inflammation Patients After Acute Coronary Syndrome Event</brief_title>
	<detailed_description>The effect VIA-2291 vascular inflammation assess 18FDG PET vascular imaging measurement various biomarkers 24 week .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Lipoxygenase Inhibitors</mesh_term>
	<mesh_term>Atreleuton</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Inclusion Criteria Female patient must nonchildbearing potential Recent acute coronary syndrome [ ( ACS ) ST elevation myocardial infarction ( STEMI ) , nonSTEMI unstable angina ) event document ECG , cardiac enzyme angiogram ] 1 3 month prior randomization Carotid ascend aorta artery plaque inflammation TargettoBackground Ratio ( TBR ) â‰¥ 1.6 Receiving concomitant statin therapy follow qualify ACS event minimum 4 week , include stable statin dose regimen 2 week prior randomization . Exclusion Criteria Renal insufficiency define creatinine &gt; 1.5 x upper limit normal ( ULN ) Cirrhosis , recent hepatitis , alanine aminotransferase ( ALT ) &gt; 1.5 x ULN ( i.e. , normal range ) positive screen test hepatitis B ( hepatitis B surface antigen ) hepatitis C ( ELISA ) Type I diabetes uncontrolled Type 2 diabetes define hemoglobin A1c ( HbA1c ) &gt; 9 % Heart failure define New York Heart Association Class III IV Coronary Artery Bypass Surgery ( CABG ) within 4 month randomization Use zileuton , montelukast , coumadin steroid Acetaminophen use form 7 day enrollment Visit 1 Allergy contrast agent Planned additional cardiac intervention ( e.g. , PCI , CABG ) within next 6 month Current atrial fibrillation , atrial flutter frequent premature ventricular contraction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Atherosclerosis</keyword>
</DOC>